A normalized equivalent dose is an analytical comparison, not proof that midazolam was administered.
What the supplied source reports
The secondary analysis examined 614 patients at eighteen centers participating in a temperature-management trial. Sedative and analgesic exposures were normalized to midazolam and fentanyl equivalents. Dosing and titration varied between centers and were associated with awakening and other outcomes.
Limits of the evidence
Sedation strategy itself was not the randomized intervention. Greater illness burden or developing complications could influence both dose and awakening. Equivalent-dose conversions simplify different medicines and do not establish identical pharmacokinetics or receptor effects. The authors did not claim causation.
Implications for expert analysis
In a forensic chronology, distinguish the conversion used by researchers from the medication administration record. Do not infer a measured midazolam concentration from an equivalent dose. Center variation and clinical indication must be considered before attributing delayed awakening to one sedative.
Source and related reading
Source: Publication PMC9935704, read from the supplied PDF. Applications to expert analysis are interpretation.
Related reading: Post-Endoscopy Lemborexant Series Had No Benzodiazepine-Free Sedation Comparator.
Leave a Reply